Page last updated: 2024-08-16

ribavirin and 9-(2',3'-dihydroxycyclopent-4'-enyl)adenine

ribavirin has been researched along with 9-(2',3'-dihydroxycyclopent-4'-enyl)adenine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Borchardt, RT; Cai, S; Kuczera, K; Li, QS; Schowen, RL	1

Other Studies

1 other study(ies) available for ribavirin and 9-(2',3'-dihydroxycyclopent-4'-enyl)adenine

Article	Year
The antiviral drug ribavirin is a selective inhibitor of S-adenosyl-L-homocysteine hydrolase from Trypanosoma cruzi. Bioorganic & medicinal chemistry, 2007, Dec-01, Volume: 15, Issue:23 Topics: Adenosylhomocysteinase; Animals; Antiviral Agents; Binding Sites; Chromatography, High Pressure Liquid; Drug Design; Enzyme Activation; Enzyme Inhibitors; Humans; Kinetics; Molecular Conformation; NAD; Recombinant Proteins; Ribavirin; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Time Factors; Trypanosoma cruzi	2007

Article

Year

The antiviral drug ribavirin is a selective inhibitor of S-adenosyl-L-homocysteine hydrolase from Trypanosoma cruzi.

Bioorganic & medicinal chemistry, 2007, Dec-01, Volume: 15, Issue:23

Topics: Adenosylhomocysteinase; Animals; Antiviral Agents; Binding Sites; Chromatography, High Pressure Liquid; Drug Design; Enzyme Activation; Enzyme Inhibitors; Humans; Kinetics; Molecular Conformation; NAD; Recombinant Proteins; Ribavirin; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Time Factors; Trypanosoma cruzi

2007